FTC Secures $12 Million in Penalties for Pre-Merger Reporting Act Violations

FTC alleges Edwards Lifesciences and Genesis structured JC Medical deal to avoid federal antitrust review The Federal Trade Commission secured $12 million in penalties to settle charges alleging that Edwards Lifesciences Corp. acquired medical device maker JC Medical from Genesis MedTech Group Limited without complying with the notification and waiting period requirements of the Hart-Scott-Rodino Act (HSR). View Press Release